Authors
Joanna Rhodes, MD, MSCE, is the director of the lymphoma program at the Rutgers Cancer Institute and assistant head of lymphoma at Robert Wood Johnson.
Christopher Shade, PhD, founder and CEO, Quicksilver Scientific.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Autoinjector for At-Home IV-Equivalent Diuresis
2
Defining Alzheimer's Disease Agitation: Diagnostic Criteria, Symptoms, and Disease Course
3
Small Workflow Changes Close Big Gaps in CKM Screening
4
Diagnosing Alzheimer's Disease Agitation: Triggers, Care Specialties, and the Role of Primary Care
5
